F2 and venous thromboembolism: While initially the drug target F2 (coagulation factor II, thrombin) for venous thromboembolism (VTE) ranked only in the top 2%, it moved up to the top 1% regardless of the network used for diffusion at r = 0.6 (top 0.9%, 0.6%, and 0.7% for STRING, CoXRNAseq, and FAVA, respectively).